DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Strosberg JR. et al.
Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review study.
Oncologist 2014;
19: 930-936
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.
